Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Vaze, Anagha; Nguyen, Vuong; Daien, Vincent; Arnold, Jennifer J; Young, Stephanie H; Cheung, Chui M; Lamoureux, Ecosse; Bhargava, Mayuri; Barthelmes, Daniel; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Ranibizumab and Aflibercept for the Treatment of Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration: Data from an Observational Study. Retina, 38(10):1954-1961.

Daien, Vincent; Nguyen, Vuong; Morlet, Nigel; Arnold, Jennifer J; Essex, Rohan W; Young, Stephanie; Hunyor, Alex; Gillies, Mark C; Barthelmes, Daniel (2018). Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project. American Journal of Ophthalmology, 190:50-57.

Barthelmes, Daniel; Nguyen, Vuong; Daien, Vincent; Campain, Anna; Walton, Richard; Guymer, Robyn; Morlet, Nigel; Hunyor, Alex P; Essex, Rohan W; Arnold, Jennifer J; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Two Year Outcomes of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially for Neovascular Age-Related Macular Degeneration. Retina, 38(1):20-28.

Barthelmes, Daniel; Campain, Anna; Nguyen, Phuc; Arnold, Jennifer J; McAllister, Ian L; Simpson, Judy M; Hunyor, Alex P; Guymer, Robyn; Essex, Rohan W; Morlet, Nigel; Gillies, Mark C; Fight Retinal Blindness! Project Investigators (2016). Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. The British Journal of Ophthalmology, 100(12):1640-1645.

Gillies, Mark C; Nguyen, Vuong; Daien, Vincent; Arnold, Jennifer J; Morlet, Nigel; Barthelmes, Daniel (2016). Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: data from an observational study. Ophthalmology, 123(12):2545-2553.

Essex, Rohan W; Nguyen, Vuong; Walton, Richard; Arnold, Jennifer J; McAllister, Ian L; Guymer, Robyn H; Morlet, Nigel; Young, Stephanie; Barthelmes, Daniel; Gillies, Mark C; Fight Retinal Blindness Study Group (2016). Treatment patterns and visual outcomes during the maintenance phase of treat-and-extend therapy for age-related macular degeneration. Ophthalmology, 123(11):2393-2400.

Gillies, Mark C; Campain, Anna; Barthelmes, Daniel; Simpson, Judy M; Arnold, Jennifer J; Guymer, Robyn H; McAllister, Ian L; Essex, Rohan W; Morlet, Nigel; Hunyor, Alex P (2015). Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study. Ophthalmology, 122(9):1837-1845.

Arnold, Jennifer J; Campain, Anna; Barthelmes, Daniel; Simpson, Judy M; Guymer, Robyn H; Hunyor, Alex P; McAllister, Ian L; Essex, Rohan W; Morlet, Nigel; Gillies, Mark C (2015). Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration. Ophthalmology, 122(6):1212-1219.

O'Day, Roderick F; Barthelmes, Daniel; Zhu, Meidong; Wong, Tien Y; McAllister, Ian L; Arnold, Jennifer J; Gillies, Mark C (2014). Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial. BMC Ophthalmology, 14:123.

This list was generated on Sat Apr 20 01:20:01 2019 CEST.